HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

lysine-sepharose

affinity chromatography

Also Known As:

Lys-sepharose; lysine sepharose

Networked: 8 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Carbohydrates: 22023
- Polysaccharides: 15383
  - Sepharose: 2476
    - lysine-sepharose: 8

Experts

1.	Blajchman, Morris A: 1 article (05/2002)
2.	Clarke, Bryan J: 1 article (05/2002)
3.	Hatton, Mark W C: 1 article (05/2002)
4.	Korbie, Darren: 1 article (05/2002)
5.	Legault, Kimberly: 1 article (05/2002)
6.	Marien, Lindsay: 1 article (05/2002)
7.	Richardson, Mary: 1 article (05/2002)
8.	Ross, Bonnie L: 1 article (05/2002)
9.	Singh, Gurmit: 1 article (05/2002)
10.	Southward, Suzanne M R: 1 article (05/2002)

Related Diseases

1.	Atherosclerosis 05/01/1998 - "In conclusion, this study suggests that the presence of either a Met66 or a Thr66 residue in K.IV type 10 of apo(a) has no consequences for the binding characteristics of Lp(a) toward lysine-Sepharose or Desafib-X, nor is it associated with the presence of symptomatic atherosclerosis."
2.	Melanoma (Melanoma, Malignant) 12/17/1985 - "Two variants (I and II) of tissue-type plasminogen activator (t-PA) from human melanoma cells were separated by Lysine Sepharose chromatography. " 12/01/1986 - "Recombinant tissue-type plasminogen activator (rt-PA) from cultures of a genetically manipulated Bowes melanoma cell line (TRBM6) was purified in batches of average volume 451 using an autoclavable, reusable, continuous chromatography system comprising zinc chelate-Sepharose CL4B and lysine-Sepharose CL4B. " 07/18/1985 - "Tissue plasminogen activator produced by a human melanoma cell line (Bowes), was purified from large volumes of supernatant fluid using immunosorbent chromatography on monoclonal antibodies, followed by chromatography on lysine-Sepharose 4B and gel filtration on Sephadex G-150. "
3.	Ascites 10/01/1992 - "The plasminogen activator adsorbed on Lys-sepharose from the ascites was observed at the 100,000 mol wt position and in the 50,000-100,000 mol wt range on zymography and appeared at the 50,000 mol wt position after treatment by concentration. " 06/01/1985 - "Plasminogen activator (ascites PA) was purified from the ascites of the patient with breast cancer using lysine-Sepharose, salting out, DEAE Sephadex A-50 and anti-urokinase (UK) Sepharose chromatography. "
4.	Pemphigus (Pemphigus Vulgaris) 09/01/1985 - "Both pemphigus IgG and the complement source were depleted of plasminogen by passage over a lysine-Sepharose 4B column, and tested for their effects on cell detachment depleted of plasminogen. "
5.	Neoplasms (Cancer) 05/01/2002 - "Effusate was collected from six rabbits with high tumor burdens and fractionated by means of lysine-Sepharose chromatography. "

Related Drugs and Biologics

1.	Apolipoproteins A
2.	Tissue Plasminogen Activator (Alteplase)
3.	Plasminogen Activators (Plasminogen Activator)
4.	Urokinase-Type Plasminogen Activator (Urokinase)
5.	Sepharose (Agarose)
6.	Plasminogen
7.	Immunosorbents
8.	Immunoglobulin G (IgG)
9.	Complement System Proteins (Complement)
10.	Monoclonal Antibodies

Related Therapies and Procedures

1.	Aftercare (After-Treatment)